知镜 Cognispect · 医学文献与研究工作台

Synergistic effects of glucocorticoid and N 2 -gas cold atmospheric plasma in a mouse model of atopic dermatitis.

Ohira C, Komai N, Inaba Y, Hamauzu A, Kaneki M, Nagane M, Nakamura M, Miyasato K, Nagahara Y, Kai H, Miyamoto E, Morooka A, Nagata M, Fukuyama T.
International immunopharmacology · 2026-05-14 · PMID 42134290

文献摘要

Atopic dermatitis (AD) is characterized by impaired skin barrier function, chronic inflammation, and increased susceptibility to infection. Although topical glucocorticoids are effective, long-term use is limited by adverse effects, highlighting the need for steroid-sparing strategies. This study investigated the immunomodulatory and therapeutic effects of nitrogen-based cold atmospheric plasma (N₂-CAP), alone and in combination with topical clobetasol propionate, in murine models of burn injury and AD. Burn wounds in mice were treated daily with N₂-CAP for 15 or 60 s. A human epidermal keratinocyte cell line (HaCaT) was used to assess proliferation, scratch closure, and cytokine release following TNFα/IFNγ or Dermatophagoides farinae stimulation. Preventive and therapeutic AD models were treated daily with N₂-CAP, 0.05% clobetasol propionate (CP), or combination therapy (N₂-CAP plus reduced CP). Clinical severity, transepidermal water loss (TEWL), skin thickness, histology, immune cell infiltration, cytokine production, serum IgE, and RNA sequencing were evaluated. Daily 60 s N₂-CAP accelerated burn wound closure, enhanced keratinocyte proliferation, and reduced pro-inflammatory cytokine production in vitro. In AD models, N₂-CAP significantly reduced clinical scores, TEWL, skin thickening, and Th2 cytokines, showing efficacy comparable to that of CP. Combination therapy yielded additive therapeutic effects. Transcriptomic analysis revealed that N₂-CAP predominantly downregulated inflammatory pathways, whereas CP enhanced barrier-related gene expression; combination therapy additively modulated both processes. These findings indicate that N₂-CAP exerts significant immunomodulatory effects in experimental AD and may serve as a complementary, steroid-sparing therapeutic strategy. N₂-CAP represents a promising non-pharmacological approach for managing inflammatory skin disease.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。